G protein polymorphisms do not predict weight loss and improvement of hypertension in severely obese patients

Journal of Gastrointestinal Surgery

Volumn 8, Issue 7, 2004, Pages 862-868

  Potoczna, Natascha ^a   Wertli, Maria ^a   Steffen, Rudolph ^b,c   Ricklin, Thomas ^b,c   Lentes, Klaus Ulrich ^d   Horber, Fritz F ^a,b,c  

^a KLINIK HIRSLANDEN   (Switzerland)

^b Department of Surgery   (Switzerland)

^c Department of Surgery   (Switzerland)

^d Bioscientia Center for Human Genetics   (Germany)

Author keywords

G protein; GNAS1 T393C; GNB3 C825T; GNB3 G814A; Severe obesity; Treatment outcome

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; FEMALE; GASTROPLASTY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; REOPERATION; TIME; WEIGHT REDUCTION;

ADULT; FEMALE; GASTROPLASTY; GENOTYPE; GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; MALE; MULTIVARIATE ANALYSIS; OBESITY; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REOPERATION; TIME FACTORS; WEIGHT LOSS;

EID: 16644394116     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gassur.2004.08.004     Document Type: Article

References (44)

1. Comuzzie AG, Allison DB. The search for human obesity genes. Science 1998;280:1374-1377.
2. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Geneva, Switzerland: 1998, World Health Organization, WHO/NUT/NCD/98.1.
3. Nestle M. The ironic politics of obesity. Science 2003;299:781.
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
5. Klein S, Wadden T, Sugerman HJ. AGA technical review on obesity. Gastroenterology 2002;123:882-932.
6. Kral JG. Surgical treatment of obesity. In Bray GA, Bouchard C, James WPT, eds. Handbook of Obesity. New York: Marcel Dekker, 1998, pp 977-993.
7. Steffen R, Biertho L, Ricklin Th, et al. Laparoscopic adjustable gastric banding: A five-year prospective study. Obes Surg 2003;13:404-411.
8. Hauner H, Meier M, Jockel KH, et al. Prediction of successful weight reduction under sibutramine therapy through genotyping of the G-protein beta3 subunit gene (GNBS) C825T polymorphism. Pharmacogenetics 2003;13:453-459.
9. Frey U, Hauner H, Bachmann H, et al. Der G-Protein alpha s (GNAS1) T393C-Polymorphismus als Prädiktor für erfolgreiche Gewichtsreduktion und kardiovaskuläre Nebenwirkungen unter Therapie mit Sibutramin. Aktuel Ernaer 2003;28:311-347.
10. Rosskopf D, Manthey I, Habich C, et al. Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit. Biochem J 2003;371(Pt 1):223-232.
11. Siffert W. Cardiovascular pharmacogenetics: On the way toward individually tailored drug therapy. Kidney Int Suppl 2003;84:S168-S171.
12. Zill P, Baghai TC, Zwanzger P, et al. Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment. Neuroreport 2000;11:1893-1897.
13. Schafers RF, Nurnberger J, Rutz A, et al. Haemodynamic characterization of young normotensive men carrying the 825T-allele of the G-protein beta3 subunit. Pharmacogenetics 2001;11:461-470.
14. Zeltner R, Delles C, Schneider M, et al. G-protein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 2001;37:882-886.
15. Dobrev D, Wettwer E, Himmel HM, et al. G-protein beta(3)-subunit 825T allele is associated with enhanced human atrial inward rectifier potassium currents. Circulation 2000;102:692-697.
16. Hauner H, Rohrig K, Siffert W. Effects of the G-protein beta3 subunit 825T allele on adipogenesis and lipolysis in cultured human preadipocytes and adipocytes. Horm Metab Res 2002;34:475-480.
17. Ryden M, Faulds G, Hoffstedt J, et al. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes 2002;51:1601-1608.
18. Lindemann M, Virchow S, Ramann F, et al. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett 2001;495:82-86.
19. Morrison AC, Doris PA, Folsom AR, et al. Atherosclerosis Risk in Communities Study. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 2001;32:822-829.
20. Poch E, Gonzalez D, Gomez-Angelats E, et al. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 2000;35:214-218.
21. Siffert W, Forster P, Jöckel K-H, et al. Worldwide ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 1999;10:1021-1030.
22. Gutersohn A, Naber C, Muller N, et al. G-protein beta3 825TT genotype and post-pregnancy weight retention. Lancet 2000;51:1601-1608.
23. Hocher B, Slowinski T, Stolze T, et al. Association of maternal G protein beta3 subunit 825T allele with low birthweight. Lancet 2000;355:1241-1242.
24. Beige J, Engeli S, Ringel J, et al. Donor G protein beta3 subunit 825TT genotype is associated with reduced kidney allograft survival. J Am Soc Nephrol 1999;10:1717-1721.
25. Kato N, Sugiyama T, Morita H, et al. G-protein b3 subunit variant and essential hypertension in Japanese. Hypertension 1998;32:935-938.
26. Larson N, Hutchinson R, Boerwinkle E. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension 2000;35:1297-1300.
27. Snapir A, Heinonen P, Tuomainen TP, et al. G-protein b3 subunit C825T polymorphism: No association with risk for hypertension and obesity. J Hypertens 2001;19:2149-2155.
28. Benjafield AV, Lin RCY, Dalziel B, et al. G-protein b3 subunit gene splice variant in obesity and overweight. Int J Obes 2001;25:777-780.
29. Rosskopf D, Busch S, Manthey I, et al. G protein b3 gene: Structure, promoter, and additional polymorphisms. Hypertension 2000;36:33-41.
30. Sokel RR, Rolf FJ. Biometry. New York: WH Freeman and Co, 1981, p 765.
31. Branson R, Potoczna N, Kral JG, et al. Binge eating as a major phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;348:1096-1103.
32. Hauri P, Steffen R, Ricklin T, et al. Treatment of morbid obesity with the Swedish Adjustable Gastric Band (SAGB): Complication rate during a 12-month follow-up period. Surgery 2000;127:484-488.
33. Wiesner W, Weber M, Hauser RS, et al. Anterior versus posterior slippage: Two different types of eccentric pouch dilatation in patients with adjustable gastric banding. Dig Surg 2001;18:182-186.
34. James WP, Astrup A, Finer N, et al. Effect of sibutramine on weight maintenance after weight loss: A randomised trial. Lancet 2000;356:2119-2125.
35. Zoss I, Piec G, Horber FF. Impact of orlistat therapy on weight reduction in morbidly obese patients after implantation of the Swedish Adjustable Gastric Band. Obes Surg 2002;12:113-117.
36. Steffen R, Horber F, Hauri P. Swedish Adjustable Gastric Band (SAGB)-distal gastric bypass: A new variant of an old technique in the treatment of superobesty and failed band restriction. Obes Surg 1999;9:171-176.
37. Gagner M, Steffen R, Biertho L, et al. Laparoscopic adjustable gastric banding with duodenal switch for morbid obesity: Technique and preliminary results. Obes Surg 2003;13:444-449.
38. Hellmich N. Obesity on track as No. 1 killer. USA Today. Available at: http://www.usatoday.com/news/health/2004-03-09-obesity_x.htm. Accessed September 12, 2004.
39. O'Brien PE, Dixon JB. Lap-band: Outcomes and results. J Laparoendosc Adv Surg Tech A 2003;13:265-270.
40. Kral JG, Branson R, Piec G, et al. Melanocortin-4 receptor gene variants affect results of gastric banding. J GASTROINTEST SURG 2004;126(Suppl 2):A774.
41. Kral JG, Lentes K-U, Horber FF. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med 2003;349:606-609; author reply 606-609.
42. Davy KP, Hall JE. Obesity and hypertension: Two epidemics or one? Am J Physiol Regul Integr Comp Physiol 2004;286:R803-R813.
43. Siffert W, Rosskopf D, Erbel R. Genetic polymorphism of the G-protein beta3 subunit, obesity and essential hypertension. Herz 2000;25:26-33.
44. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001;134:1-11.